ClinicalTrials.gg
Active, not recruitingNCT05499507Updated Aug 5, 2026

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

An interventional study of COH and COH+ in Pregnancy Related, Hypertension and Obesity, sponsored by Temple University. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Temple University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
345
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.

Read the detailed description

What is this research about? Heart disease (e.g., heart attack, stroke) is a major threat to safe motherhood and is the leading cause of maternal death in the United States, responsible for nearly 50 percent of pregnancy-related deaths among Black women, three times the rate of white women, and is largely preventable. It is well established that eating healthy foods and monitoring blood pressure can help prevent heart disease. While prior studies addressing these individual behaviors have led to some success, a single individual-level approach has not been enough to stop the rising rate of Black maternal mortality. Researchers have also established that depression, social isolation, and stress from racism lead to poor heart outcomes. But few studies have treated these psychosocial and structural factors in addition to individual behaviors to ensure optimal Black maternal heart health, particularly for mothers at higher risk (e.g., those with high blood pressure and/or obesity). To meet this need, the research team plans to compare two approaches that treat multiple factors leading to heart disease among patients age 18 and older who self-identify as Black or African American, have either obesity and/or high blood pressure, are less than 28 weeks pregnant, and have a smart phone. Both approaches address individual behaviors through nutrition and physical activity text messages and home blood pressure self-monitoring as well as provide training to medical care providers in order to reduce patients' experiences of racism or mistreatment. But only one of the approaches being studied also adds supports for Black women by Black women (community doula care, mental health services, and lactation consultation) during their pregnancy, birth, and postpartum in order to learn if these supports lead to lower blood pressure and also treat social isolation, depression, and increase experiences of respectful maternity care.

Who can this research help? This study will increase Black mothers' understanding of the many influences on their heart health. Findings from this study will help Black women with obesity and/or high blood pressure make informed decisions about the use of community doulas, lactation professionals, and psychotherapists as part of their care to reduce risks for heart disease during pregnancy or in the first year after their baby is born. Results may also strengthen health systems' commitment to anti-racism training as part of their efforts to provide quality health care for Black pregnant and postpartum people. And further, this research may provide evidence to insurance companies that coverage of this study's package of supports is needed.

What outcomes are being studied? The primary outcomes are changes in maternal blood pressure and body weight at six weeks and one year after giving birth. The team will also evaluate how well the treatments are implemented and able to reach patients, be adopted into practice consistently, and lead to healthcare provider and patient satisfaction. The team will analyze outcomes that patient partners have identified as important. These include perinatal mood and anxiety disorders (e.g., postpartum depression), emotional and informational support, stress, and experiences of respectful maternity care. In addition, the study team will look at clinical outcomes including if and for how long patients breastfeed, blood pressure disorders of pregnancy, how the patient gave birth (e.g., vaginal or cesarean), baby's birth weight, and how many weeks pregnant mothers were at the time of birth.

How long does this study last? Final follow-up of primary outcomes is at one year postpartum (i.e., approximately 18 months from enrollment).

How are stakeholders involved? The research team believes that efforts to improve Black maternal heart health will be most effective when partnered with patients and community leaders that have shared lived experience. Study leadership is an equitable partnership by an academic physician-researcher and community-based Black provider who herself experienced heart health complications in her pregnancy. There are three other patient investigators who will also be involved in all aspects of the planning, delivery, and evaluation of the treatments, including serving as lead doulas, therapists, and lactation professionals. Patient representatives will make up the majority of the study's advisory board to give feedback and further guide the team's efforts throughout the five years of the project. Finally, patient, health system, and community provider stakeholders will provide feedback and guidance through focus groups over the entire study duration to ensure adoption of treatments.

02

Conditions studied

  • Pregnancy Related
  • Hypertension
  • Obesity
  • Racism
03

In context

Hypertension

6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.

This study's enrollment of 345 is above the median of 100 across 4,575 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Temple University is the lead sponsor of 223 studies on the registry; 29 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 7 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • age ≥18 years
  • baseline ≥30 kg/m2 and/or diagnosis of HTN (≥130/80 x 2)
  • gestational age ≤28 weeks by last menstrual period
  • smartphone ownership
  • self-identification as Black or African American
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
345 participants (actual)

Study arms

  • Active comparator
    Change of Heart (COH)

    Incorporates two, evidence-based individual-level interventions (home blood pressure telemonitoring coupled with the interactive obesity treatment approach, that includes nutrition and physical activity text messages with tailored feedback) and an institutional-level intervention (anti-racism training of providers and staff along with patient feedback to inform respectful care).

    Behavioral: COH

  • Experimental
    Change of Heart Plus (COH+)

    Includes all components of COH plus the addition of interpersonal support for Black women by Black women (community doula care, mental health services, and lactation support).

    Behavioral: COH+

Interventions

  • BehavioralCOH

    Incorporates two, evidence-based individual-level interventions (home blood pressure telemonitoring coupled with the interactive obesity treatment approach, that includes nutrition and physical activity text messages with tailored feedback) and an institutional-level intervention (anti-racism training of providers and staff along with patient feedback to inform respectful care).

  • BehavioralCOH+

    Includes all components of COH plus interpersonal support for Black women by Black women (community doula care, mental health services, and lactation support).

06

What researchers measure

Primary outcomes

  1. Change in blood pressure at 6-weeks postpartum.

    Blood pressure will be measured at each time point on the upper arm three times at one-minute intervals after five minutes of quiet sitting. The investigators will use the validated Omron HEM-907XL and the appropriate size cuff. The investigators will average the three measures for analysis.

    Time frame: At baseline and 6-weeks postpartum

  2. Change in blood pressure at 12-months postpartum.

    Blood pressure will be measured at each time point on the upper arm three times at one-minute intervals after five minutes of quiet sitting. The investigators will use the validated Omron HEM-907XL and the appropriate size cuff. The investigators will average the three measures for analysis.

    Time frame: At baseline and 12-months postpartum

  3. Change in body weight at 6-weeks postpartum.

    Body weight will be measured in duplicate and recorded to the nearest 0.1kg using calibrated SECA scales at each time point.

    Time frame: At baseline and 6-weeks postpartum

  4. Change in body weight at 12-months postpartum.

    Body weight will be measured in duplicate and recorded to the nearest 0.1kg using calibrated SECA scales at each time point.

    Time frame: At baseline and 12-months postpartum

Secondary outcomes

  1. Change in emotional support at 6-weeks postpartum.

    The investigators will use the 8-item emotional support PROMIS instrument to measure perceived feelings of being cared for at each time point. The lowest possible raw score is 8; the highest possible raw score is 40. Higher scores indicate greater emotional support.

    Time frame: At baseline and 6-weeks postpartum

  2. Change in emotional support at 12-months postpartum.

    The investigators will use the 8-item emotional support PROMIS instrument to measure perceived feelings of being cared for at each time point. The lowest possible raw score is 8; the highest possible raw score is 40. Higher scores indicate greater emotional support.

    Time frame: At baseline and 12-months postpartum

  3. Change in informational support at 6-weeks postpartum.

    The investigators will use the 8-item informational support PROMIS instruments to measure perceived availability of helpful information or advice at each time point. The lowest possible raw score is 8; the highest possible raw score is 40. Higher scores indicate greater informational support.

    Time frame: At baseline and 6-weeks postpartum

  4. Change in informational support at 12-months postpartum.

    The investigators will use the 8-item informational support PROMIS instruments to measure perceived availability of helpful information or advice at each time point. The lowest possible raw score is 8; the highest possible raw score is 40. Higher scores indicate greater informational support.

    Time frame: At baseline and 12-months postpartum

  5. Change in Perinatal Mood and Anxiety Disorders (PMADs) at 6-weeks postpartum.

    PMADs will be assessed using the Beck Depression Inventory II (BDI-II), a 21-item screening tool. The BDI-II has demonstrated concurrent validity with other postpartum depression scales and validated cut points for mild/moderate depressive symptoms in Black women of low-socioeconomic position. The lowest possible raw score is 1; the highest possible raw score is 40. Higher scores indicate greater depressive symptoms.

    Time frame: At baseline and 6-weeks postpartum

  6. Change in PMADs at 12-months postpartum.

    PMADs will be assessed using the Beck Depression Inventory II (BDI-II), a 21-item screening tool. The BDI-II has demonstrated concurrent validity with other postpartum depression scales and validated cut points for mild/moderate depressive symptoms in Black women of low-socioeconomic position. The lowest possible raw score is 1; the highest possible raw score is 40. Higher scores indicate greater depressive symptoms.

    Time frame: At baseline and 12-months postpartum

  7. Mothers autonomy in decision making at baseline.

    The 7-item Mothers Autonomy in Decision Making scale rates patients' level of agency and autonomy experienced during conversations with a maternity provider. The range of scores is 7-42, with higher scores indicating more opportunities to take an active role and lead decisions.

    Time frame: Baseline

  8. Mothers autonomy in decision making at 6-weeks postpartum.

    The 7-item Mothers Autonomy in Decision Making scale rates patients' level of agency and autonomy experienced during conversations with a maternity provider. The range of scores is 7-42, with higher scores indicating more opportunities to take an active role and lead decisions.

    Time frame: 6-weeks postpartum

  9. Respectful maternity care at baseline.

    Respectful maternity care will be assessed by the 14-item Mothers on Respect Index, which examines the nature of provider-patient relationships and access to person-centered care. The range of scores is 14-84, with higher scores indicating more respectful care. lead decisions.

    Time frame: Baseline

  10. Respectful maternity care at 6-weeks postpartum.

    Respectful maternity care will be assessed by the 14-item Mothers on Respect Index, which examines the nature of provider-patient relationships and access to person-centered care. The range of scores is 14-84, with higher scores indicating more respectful care.

    Time frame: 6-weeks postpartum

  11. Obstetric mistreatment at baseline.

    The 8-item Mistreatment Index queries patients' experience of dimensions of mistreatment (e.g., physical abuse, discrimination). To describe the overall prevalence of mistreatment, the investigators will calculate the proportion of women who experienced each of the seven types of mistreatment and what proportion experience any mistreatment (i.e. any of the seven indicators).

    Time frame: Baseline

  12. Obstetric mistreatment at 6-weeks postpartum

    The 8-item Mistreatment Index queries patients' experience of dimensions of mistreatment (e.g., physical abuse, discrimination). To describe the overall prevalence of mistreatment, the investigators will calculate the proportion of women who experienced each of the seven types of mistreatment and what proportion experience any mistreatment (i.e. any of the seven indicators).

    Time frame: 6-weeks postpartum

  13. Blood pressure control at 6-weeks postpartum for patients with hypertension (HTN) at baseline.

    Blood pressure control will be assessed at each time point for patients with HTN at enrollment (proportion with mean systolic BP ≥ 130mm/Hg or mean diastolic BP ≥ 80mm/Hg).

    Time frame: 6-weeks postpartum

  14. Blood pressure control at 12-months postpartum for patients with hypertension at baseline.

    Blood pressure control will be assessed at each time point for patients with HTN at enrollment (proportion with mean systolic BP ≥ 130mm/Hg or mean diastolic BP ≥ 80mm/Hg).

    Time frame: 12-months postpartum

  15. Incident hypertension at 6-weeks postpartum for patients who were normotensive at baseline.

    Data will be collected about incident HTN at 6-weeks and 1-year postpartum for normotensive patients at enrollment (proportion with mean systolic BP ≥130 mm/Hg or mean diastolic BP ≥ 80mm/Hg).

    Time frame: 6-weeks postpartum

  16. Incident hypertension at 12-months postpartum for patients who were normotensive at baseline.

    Data will be collected about incident HTN at 6-weeks and 1-year postpartum for normotensive patients at enrollment (proportion with mean systolic BP ≥130 mm/Hg or mean diastolic BP ≥ 80mm/Hg).

    Time frame: 12-months postpartum

  17. Breast/Chestfeeding initiation.

    Breast/chestfeeding initiation will be assessed via questions adapted from the Infant Feeding Practices Study II.

    Time frame: 6-weeks postpartum

  18. Breast/Chestfeeding duration.

    Breast/chestfeeding duration will be assessed via questions adapted from the Infant Feeding Practices Study II.

    Time frame: 12-months postpartum

  19. Breastfeeding support/self-efficacy at 6-weeks postpartum.

    Breast/chestfeeding self-efficacy will be assessed via questions adapted from the Breastfeeding Self-Efficacy Scale. The range of scores is 14-70, with higher scores indicating greater self-efficacy.

    Time frame: 6-weeks postpartum

  20. Breastfeeding support/self-efficacy at 12-months postpartum.

    Breast/chestfeeding self-efficacy will be assessed via questions adapted from the Breastfeeding Self-Efficacy Scale. he range of scores is 14-70, with higher scores indicating greater self-efficacy.

    Time frame: 12-months postpartum

  21. Mode of delivery.

    Mode of delivery will be abstracted from the electronic health record and categorized as either operative delivery (cesarean section) or non-operative (vaginal delivery), stratified by birth history.

    Time frame: 6-weeks postpartum

  22. Infant birth weight.

    Infant birth weight will be abstracted from electronic health record. The investigators will calculate sex-specific birth weight for gestational age percentile based on national data.

    Time frame: 6-weeks postpartum

  23. Preterm birth.

    To determine rates of preterm birth, gestational length will be calculated from last menstrual period (LMP) unless ultrasound dating differs ≥10 days from LMP dating. Pregnancy loss will be assessed by self-report, verified by electronic health record.

    Time frame: 6-weeks postpartum

07

Study locations

1 site
08

References and documents

Publications

  • Wycoff KL, Coleman JG, Santoro CM, Zullig LL, Darden N, Holland PM, Cruice JF, Mitchell S, Smith M, McNeil SJ, Herring SJ. Multilevel Community Engagement to Inform a Randomized Clinical Trial. Obstet Gynecol. 2023 Oct 1;142(4):929-939. doi: 10.1097/AOG.0000000000005344. Epub 2023 Sep 7. PubMed 37734093 ↗

Individual participant data

Plan to share: Yes — Descriptions of the study dataset, including codebooks and documentation of the programming code used for creating the final study population, variable definitions, and descriptive and outcome analyses will be provided at the end of the final funding year. The investigators will make these materials, as well as the final dataset, available via the Inter-university Consortium for Political and Social Research (ICPSR, https://www.icpsr.umich.edu/web/pages/) of which Temple University is a member.

Time frame: 8/10/2028

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05499507
Lead sponsor
Temple University
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Sponsor
First posted
Aug 12, 2022
Start date
Jan 24, 2023
Primary completion
Jul 15, 2027 (estimated)
Completion
Jan 9, 2029 (estimated)
Last update
Aug 5, 2026

Study contacts

Sharon J Herring, MD, MPH
principal investigator · Temple University, Philadelphia, Pennsylvania, United States, 19140

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion